Skip to main content
. 2012 Aug 9;7:49. doi: 10.1186/1750-1172-7-49

Table 1.

Overview of target antigens in immunobullous diseases and diagnostic methods used in this study

Disease Target antigen Routine multi-step approach1
Pemphigus vulgaris
Desmoglein 3
Desmoglein 3 ELISA[22]
Pemphigus foliaceus
Desmoglein 1
Desmoglein 1 ELISA[22]
Paraneoplastic pemphigus
Desmoglein 3
Desmoglein 3 ELISA[22]
Envoplakin
Envoplakin ELISA[21]
Periplakin/ Desmoplakin I/II
Immunoblot with extract of cultured HaCaT cells [21]
Indirect IF microscopy on rat and monkey bladder
Bullous pemphigoid
BP180
BP180 NC16A ELISA[20]
BP230
BP230 ELISA[51]
Soluble ectodomain of BP180 (LAD-1)
BP180 4575 (c-terminal fragment) Immunoblot [33,63]
LAD-1 Immunoblot [33,63]
Pemphigoid gestationis
BP180
BP180 NC16A ELISA[20]
Complement binding test
Linear IgA dermatosis
Soluble ectodomain of BP180 (LAD-1)
Immunoblot with conditioned medium of cultured HaCaT cells (IgA reactivity) ) [33,63]
BP230
BP230 ELISA[51]
Lichen planus pemphigoides
BP180
BP180 NC16A ELISA[51]
BP230
BP230 ELISA[51]
Mucous membrane pemphigoid
Soluble ectodomain of BP180 (LAD-1)
Immunoblot with conditioned medium of cultured HaCaT cells (IgG and IgA reactivity) [33]
BP180
BP180 NC16A ELISA [20]
BP230
BP230 ELISA [51]
Laminin 332
Immunoblot with extracellular matrix of cultured HaCaT cells [13,35]
laminin γ1/anti-p200 pemphigoid
p200 protein/ Laminin γ1
Immunoblot with extract of human dermis [34]
Immunoblot with recombinant laminin γ1 C-term [37]
Epidermolysis bullosa acquisita
Type VII collagen
Immunoblot with recombinant NC1-domain of type VII collagen [36]
Dermatitis herpetiformis Epidermal/tissue transglutaminase, gliadin Transglutaminase ELISA deamidated gliadin-analogous fusion peptide-specific ELISA [32]

1in addition, all sera were subjected to indirect IF microscopy on human salt-split skin and monkey esophagus. The exact diagnostic algorithm applied in this study is detailed in [38].

IF, immunofluorescence; LAD-1, linear IgA dermatosis antigen 1(soluble ectodomain of BP180); BP180NC16A, targeted extracellular domain of BP180.